Meeting
2015 Genitourinary Cancers Symposium
A retrospective analysis of the effect of time from diagnosis to cystectomy on survival in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy.
Authors
Jong Chul Park
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Jong Chul Park , Nilay M Gandhi , Trinity Bivalacqua , Mark Schoenberg , Michael Anthony Carducci , Mario A. Eisenberger , Alexander S Baras , George J. Netto , Jen-Jane Liu , Charles G. Drake , Noah M. Hahn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 360)
DOI
10.1200/jco.2015.33.7_suppl.360
Abstract #
360
Poster Bd #
G23
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
KEYNOTE-905/EV-303: Perioperative pembrolizumab or pembrolizumab plus enfortumab vedotin (EV) and cystectomy compared to cystectomy alone in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC).
First Author: Matt D. Galsky
Poster
2020 Genitourinary Cancers Symposium
Efficacy of neoadjuvant chemotherapy followed by resection in primary and secondary muscle-invasive bladder cancer (MIBC).
First Author: Josiah An
Poster
2020 Genitourinary Cancers Symposium
Impact of histology and toxicities on outcomes of patients with muscle invasive bladder cancer receiving neoadjuvant chemotherapy.
First Author: Catherine Curran
Poster
2019 ASCO Annual Meeting
Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC).
First Author: Benjamin Miron